Trials / Conditions / Bioequivalence Study in Healthy Subjects

Bioequivalence Study in Healthy Subjects

8 registered clinical trials studyying Bioequivalence Study in Healthy Subjects — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects NCT07015671	Sarfez Pharmaceuticals, Inc.	Phase 3
Completed	Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations NCT07127094	Aya Mohammed Abdel Magid Abdel Hamid	Phase 1
Completed	Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans NCT06924190	Lunan Better Pharmaceutical Co., LTD.	N/A
Not Yet Recruiting	Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions NCT06600282	Yung Shin Pharm. Ind. Co., Ltd.	Phase 4
Completed	Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations NCT07121868	Aya Mohammed Abdel Magid Abdel Hamid	Phase 1
Completed	Bioequivalence Assessment Between Two Perampanel Oral Suspension Formulations NCT06969963	Aya Mohammed Abdel Magid Abdel Hamid	Phase 1
Completed	Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment NCT07464340	Zodiac Produtos Farmaceuticos S.A.	Phase 1
Completed	Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations NCT02660840	H. Lundbeck A/S	Phase 1